Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0· v2Sign in
← Cases

NEK8

RBC: NEK8 · Substrate: MBP ·

Top inhibitors

MeasuredDerived
DrugInhibition %Gini
Lorlatinib81.20.69
Midostaurin74.30.50
Axitinib39.90.69
Ruxolitinib30.10.59
Vemurafenib28.10.60
Baricitinib20.00.62
Lapatinib20.00.62
Bosutinib19.80.55
Dasatinib18.90.70
Fostamatinib18.30.61
Lenvatinib17.70.73
Nilotinib17.20.77
Nintedanib16.50.61
Everolimus16.40.71
Palbociclib14.40.67

Known variants

No variants catalogued.
Open in new tab